🔗 Share this article

Texas Attorney General Ken Paxton is suing the manufacturers of Tylenol, alleging the firms hid safety concerns that the drug created to pediatric neurological development.

This legal action comes four weeks after Former President Trump publicized an unsubstantiated connection between using Tylenol - also known as acetaminophen - during pregnancy and autism spectrum disorder in children.

The attorney general is filing suit against the pharmaceutical giant, which once produced the medication, the only pain reliever suggested for women during pregnancy, and Kenvue, which currently produces it.

In a official comment, he stated they "betrayed America by making money from suffering and promoting medication ignoring the risks."

Kenvue says there is insufficient reliable data linking Tylenol to autism.

"These corporations misled for generations, deliberately risking millions to boost earnings," Paxton, a Republican, declared.

Kenvue commented that it was "seriously troubled by the spread of false claims on the safety of acetaminophen and the potential impact that could have on the well-being of women and children in America."

On its website, the company also stated it had "regularly reviewed the relevant science and there is lacking reliable evidence that indicates a verified association between using acetaminophen and autism."

Groups acting on behalf of medical professionals and healthcare providers agree.

The American College of Obstetricians and Gynecologists has declared paracetamol - the key substance in acetaminophen - is one of the few options for expectant mothers to address discomfort and elevated temperature, which can pose significant medical dangers if ignored.

"In multiple decades of research on the use of paracetamol in pregnancy, zero credible investigations has conclusively proven that the use of acetaminophen in any trimester of pregnancy results in brain development issues in children," the group said.

The court filing references latest statements from the Trump administration in arguing the drug is potentially dangerous.

Recently, the former president raised alarms from health experts when he advised pregnant women to "resist strongly" not to consume Tylenol when unwell.

The FDA then published an announcement that medical professionals should think about restricting the use of acetaminophen, while also declaring that "a causal relationship" between the drug and autism in children has not been proven.

The Health Department head RFK Jr, who manages the FDA, had pledged in April to undertake "a massive testing and research effort" that would determine the origin of autism spectrum disorder in a matter of months.

But specialists warned that finding a single cause of autism - considered by experts to be the consequence of a complex mix of inherited and surrounding conditions - would be difficult.

Autism spectrum disorder is a type of lifelong neurodivergence and condition that influences how people encounter and engage with the surroundings, and is recognized using doctors' observations.

In his legal document, Paxton - who supports Trump who is running for the Senate - asserts Kenvue and J&J "deliberately disregarded and tried to quiet the science" around acetaminophen and autism spectrum disorder.

The case aims to force the companies "eliminate any commercial messaging" that asserts Tylenol is secure for women during pregnancy.

The court case parallels the concerns of a group of guardians of children with autism and ADHD who sued the manufacturers of Tylenol in recently.

The court rejected the lawsuit, stating investigations from the family's specialists was not conclusive.